Royal Bank Of Canada Bio Sig Technologies, Inc. Transaction History

Royal Bank Of Canada

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.26 - $0.62 $9,165 - $21,856	-35,252 Reduced 74.06%	12,348 $5,000
Q3 2023 Nov 14, 2023	BUY	$0.4 - $1.39 $9,160 - $31,830	22,900 Added 92.71%	47,600 $23,000
Q2 2023 Aug 14, 2023	BUY	$1.07 - $1.55 $18,939 - $27,435	17,700 Added 252.86%	24,700 $30,000
Q1 2023 May 15, 2023	BUY	$0.42 - $1.4 $2,100 - $7,000	5,000 Added 250.0%	7,000 $7,000
Q3 2022 Nov 14, 2022	BUY	$0.56 - $6.98 $1,120 - $13,960	2,000 New	2,000 $1,000
Q1 2022 May 16, 2022	SELL	$0.99 - $2.44 $198 - $488	-200 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.18 - $3.93 $436 - $786	200 New	200 $0
Q3 2021 Nov 15, 2021	SELL	$2.71 - $4.35 $5,135 - $8,243	-1,895 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.94 - $4.75 $5,571 - $9,001	1,895 New	1,895 $8,000

88.2K

Ticker BSGM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 44,814,400
Market Cap $15.2M
Description
BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal ...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.